Improving metabolic control in sub-optimally controlled subjects with Type 1 diabetes: comparison of two treatment algorithms using insulin glargine.
Gomis, Ramon; Storms, Fred; Conget, Ignacio; Sinnassamy, Patrick; Davies, Melanie.
Diabetes Res Clin Pract
; 77(1): 84-91, 2007 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-17097185
Insulin detemir versus insulin glargine for type 2 diabetes mellitus.
Biosimilar vs originator insulins: Systematic review and meta-analysis.
Insulin degludec: Lower day-to-day and within-day variability in pharmacodynamic response compared with insulin glargine 300 U/mL in type 1 diabetes.
Basal insulin analogues in diabetic pregnancy: a literature review and baseline results of a randomised, controlled trial in type 1 diabetes.
A randomized clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 1.
The use of insulin analogues in pregnancy.
Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial.
Unmet needs in children with diabetes: the role of basal insulin.
Basal insulin peglispro: Overview of a novel long-acting insulin with reduced peripheral effect resulting in a hepato-preferential action.
Daily insulin doses and injection frequencies of neutral protamine hagedorn (NPH) insulin, insulin detemir and insulin glargine in type 1 and type 2 diabetes: a multicenter analysis of 51 964 patients from the German/Austrian DPV-wiss database.